The crystal structure of Fab Rl9.9, de. rived from an anti-p-azobenzenearsonate monoclonal antibody, has been determined and refmed to 2.8-A resolution by x-ray crystallographic techniques. Monoclonal antibody Rl9.9 (lgG2b1e) shares some idiotopes with a major idiotype (CRl.J associated with A/ J anti-p-azobenzenearsonate antibodies.
mRNAs. The v L region is very similar to that or CRIA-positive anti-p-azol>enzenearsonate antibodies as is VH, except for its third complementarity-determining region, which is three amino acids longer; it makes a loop, unique to Rl9. 9 , that protrudes into the solvent. A large n0mber or tyrosine residues in the complementarity-determining region of V 8 and V L t with their side chains pointing towards the solvent, may have an important function in antigen binding. Murine antibodies to model antigens have provided valuable experimental systems to study the molecular bases of the specificity, diversity, and genetic control of immune responses. The hapten, p-azobenzenearsonate (Ar), has been used in several laboratories as a suitable probe for such studies (1) (2) (3) (4) (5) , which have been facilitated by the presence of an intrastrain cross-reactive idiotype, designated CRIA, among the anti-Ar antibodies ofA/J mice or of closely related strains. The expression of CRIA is linked to genetic loci encoding heavy (H) chains (6) and light (L) chains (7) . On the av~rage, about half of the anti-Ar antibodies induced by keyhole limpet hemocyanin-Ar in A/J mice share this idiotype. The variable (V) regions, Vu and V L• of CRI.A antibodies appear to be encoded by single germ-line genes (8, 9) , and the diversity (D) region is encoded by a variant of the DFL16.1 gene (10) . CRI.A molecul~s also utilize the V.,10, K chain joining (J) 1, and, almost invariably, Ju2 gene segments (4, 5, 11) . Idiotypeexpressing antibodies from hyperimmunized mice display somatic variants of amino acid seq~ences in each of these gene segments (4, 5, 12) , whereas the antibodies from an early primary response reflect few if any mutations (5) . The Vu region appears to be somewhat more susceptible to somatic variation than V L (4) . A disproportionate number of mutations in Yu and V L occurs in their complementarity-determining regions (CDR); this probably reflects selection by antigen of variants with higher affinity (5) .
Among the serum anti-Ar antibodies of immunized A/J mice are molecules that carry some but not all of the idiotopes associated with CRIA (13, 14) . Such antibodies are bound by a~ti-CRIA antibodies, but they are unable to completely d1s~lac~ labele~ C~IA anti~odies from such anti-idiotype ant1bod1es. Ant1bod1es of this type were designated "minor idiotypes" (13 , 14) . The subject of the present investigation,
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monoclonal antibody (mAb) R19.9 (lgG2bK), has these serological properties and is thus a member of a minor idiotypic anti-Ar family . The L chains of Rl9.9, when combined with H chains of a CRI.A mAb, yielded a CRIA product (14) .
However, the converse recombinant (H 19 . 9 LcR 1 ) was CRIA by the criterion of inhibition in the standard assay for CRIA. Amino acid sequences (this paper) indicate that the V "10, J.,l, Yu, and Ju2 sequences of R19.9 are closely related to the putative germ-line sequences controlling CRIA but that the Du sequence (in CDR3 of Ytt) differs markedly ; it is 3 residues longer than the characteristic Du sequence (11 vs. 8 residues). There are also three amino acid substitutions in CDR2 of Vu that may contribute to the idiotypic variance of R19.9.
The x-ray crystallographic study of Fab R19.9 presented here permits a correlation between amino acid sequences, idiotypic markers, and the three-dimensional structure of the A/J anti-Ar antibodies. Tentative conclusions can also be drawn about the conformation of the antigen-combining site of anti-Ar molecules.
MATERIALS AND METHODS
The monoclonal, A/J anti-Ar antibody R19.9 (lgG2bK) was prepared as described (15, 16) . After papain digestion (17) , the Fab fragment of Rl9.9 was extensively purified by three successive column chromatography steps with Sephadex G-100 (Pharmacia), DEAE-cellulose (0. 76 milliequivalent per g; Serva, Heidelberg) equilibrated in 0 .04 M potassium phosphate buffer, and PBE 94 (Pharmacia) for chromatofocusing. In this last step, the Fab was eluted with Polybuffer 96 (Pharmacia) as a major peak at pH 7.5-7.6. The purified Fab ofR19.9 was crystallized at room temperature by vapor diffusion in hanging drops (18) X-ray intensity data were measured on a diffractometer with CuKa radiation. Since the crystals of Fab R19.9 are polymorphic (19), they were carefully selected to conform to the unit cell dimensions given above. Crystals were replaced with the intensities of reference reflections decreased below 70% of their starting values. Integrated intensities were obtained by profile fitting (20) and were further corrected for Lorentz-polarization factors , absorption (21) , and radiation decay. For the native crystals, a complete data set to 2. §To whom reprint requests should be addressed. resolution was obtained from 26,284 measurements that were merged to yield the intensities of 13,138 independent reflections (Rsym = 0.074). Three heavy atom derivatives were obtained by using phenylmercury(II) acetate, p-hydroxymethylbenzenesulfonate, and OsC~. Their intensities were measured to 3.5-A [phenylmercury(II) acetate and phydroxymethylbenzenesuJfonate] and 6-A (OsC~) resolution. After refinement of he~vy atom occupancies, scale factors, and thermal (isotropic) and positional parameters, an electron density map was calculated to 3.5-A resolution (average figure of merit, m = 0.52). The interpretation of this map was facilitated by a six-dimensional real space search by using the model ofFab New (22) Proc. Natl. Acad. Sci. USA 86 (1989) polypeptide chain. The amino acid sequence of Fab RI9.9 was adjusted to the electron density map using the program FRODO (26) on a PS300 Evans and Sutherland interactive graphics system. The model was refined by the restrained least-squares program PROLSQ (27) by using reflections between IO-and 2.8-A resolution. After 33 cycles of refinement (R = 32.4%), the model was partially rebuilt based on difference Fourier (2Fca1c -Fobs• aca1c) and "OMIT" (28) maps, as well as inspection of the solvent-flattened electron density map. The structure was further improved by alternating model building on difference Fourier and OMIT maps followed by PROLSQ refinement until reasonable convergence was achieved (see Table I ). The current R factor is 0.296. No attempt was made to place solvent molecules in the model.
Sequencing of polysomal mRNA for V Hand V" was carried out according to Griffiths and Milstein (29) by using primers described previously (30, 3I).
RESULTS
The 3.5-A resolution electron density map described above was used to fit the amino acid sequences of the variable regions [VH, D, and JH2 and also V" and J,, (see Figs. I and 2)) and those of the constant regions, CHI of IgG2b and C,, (32) . Since the sequence of V H was determined for residues I6-123 only, the first I5 residues were assumed to be the same as those in protein 36-65, which expresses the germline-encoded V H sequence of CRI~ (8) . This choice seemed reasonable because the same V H germ-line gene is expressed in 36-65 and Rl9.9 and because in 11 published N-terminal sequences ofCRIA mAbs there is a total of only seven amino acid substitutions in this region (33, 34) . Although the electron density maps gave an indication for the trace of the po}ypeptide chain in CDR3 ofVH, the detailed conformation of this region was less clear than that of other parts of Fab Rl9.9. VH positions 34, 55, 58, 59, and 74 differ from those of the germ-line VH gene; however, the electron density map showed good agreement with the experimentally determined VH sequence (Fig. 1) at those positions. Although the a!llbiguity (His/ Asp) at V H position 105 cannot be resolved with certainty by the electron density map, aspartic acid -
? R R19.9
-------~I-1-<CG FtG. 2. Nucleotide and deduced amino acid sequences of the V K region of mAb R19.9. Comparison is made with sequences of the V "10-Ars-A and J"l genes that encode CRI,t mAb (9) . See legend to Fig. 1. ? , undetermined nucleotide.
seems to be the best choice. Electron density features in V L positions 31, 55, and 107 correspond reasonably well with the amino acid sequence encoded by the V "10-Ars-A germ-line gene that encodes the V L region of CRIA antibodies and to the J"l germ-line sequence (Fig. 2) . At position 105, where an ambiguity in the nucleotide sequence is consistent with the presence of alanine, glutamic acid, glycine, or valine, the electron density map favors glutamic acid, in agreement with the germ-line J"l sequence.
The domain structure of Fab R19.9 closely follows that observed for all Fabs whose three-dimensional structure has been determined by x-ray diffraction to date (reviewed in refs. 35 and 36) . The quaternary structure of Fab R19.9 is that of an extended conformation. This conformation is usually described by reference to an "elbow" angle made by the pseudo 2-fold axes relating V H to V Land CHl to CL. For Fab Rl9.9 this angle is 178°, which is the largest (closest to 180°) so far observed in Fab structures. The rotation-translation operations necessary to superimpose selected a-carbon backbones of V H and V L are 175° and 0.45 A, respectively, indicating a nearly ideal symmetry relationship between those domains. The numerical values for the corresponding operations in the CHl-CL domains are 168° and 1.5 A, values similar to those of other known Fab structures.
A measure of the closeness of the Fab R19.9 structure to that of several other Fab molecules can be obtained by analyzing the shifts in the relative positions of packed {3-sheets (37) . Thus, if the spatial superposition of the V H or V L {31 sheets is optimized, the {32 sheets of different Fabs Qisted in Table 2 ) are no further away than an average of0.55
A and a rotation angle of 9° from the corresponding sheet of Fab R19.9.
The relative disposition of V Hand V Lin Fab R19.9 can be further compared to those of other Fabs by superposing the a-carbon coordinates of the residues that define the interface between the V Hand V L subunits, as described in Table 2 . The largest deviations that were observed for Fab R19.9 are 1.5 A and 12.8°. These deviations and others observed with different Fabs do not appear to be significant.
DISCUSSION
The three-dimensional structure ofFab R19.9 presented here provides a structural model of a specific hapten-binding mAb of predefined specificity. The calculation of electron density maps at 2.8-A resolution by x-ray crystallographic techniques and the determination of amino acid sequences (through nucleotide sequencing of the mRN As) of V H and V L allowed the tracing of most of the polypeptide chain. However, although the general position of V H CDR3 is clearly indicated in the different electron density maps that were calculated, its side chains could not be placed unambiguously. The ambiguity may arise from an intrinsic high mobility of V H CDR3. This possibility is supported by the fact that the long V H CDR3 loop protrudes into the solvent beyond other parts of the molecule (see Fig. 3 ).
The three-dimensional structure of Fab Rl9.9 agrees well with those of other Fabs that have been determined. It displays the largest elbow angle that has been observed in Fabs, in agreement with the idea that an extended (or contracted) conformation is independent of ligand binding to the combining site. As shown in Table 2 , the relative disposition of VH and VL in Fab R19.9 is well within a spectrum of angular and translational values observed in a number of Fabs, irrespective of their human or murine origin or of their liganded or unliganded state. The difference in relative disposition of V H and V L observed by Colman et al. (45) in a neuraminidase complex falls in the range of those observed in Table 2 , indicating that formation of a complex with (41) were obtained from the Brookhaven Data Bank (42, 43) , and those of Fab 01.3 (44) were obtained from the authors. The V L domain of the Fab corresponding to each horizontal row was mapped into the V L of the Fab in the column by using a-carbon coordinates of residues defining the interface between VH and VL domains (45) . The cakulated transformation was applied to the Fab corresponding to the horizontal row, and the additional translation (A) and rotation ( antigen is not necessary to produce the observed variability in the relative disposition of V H and V L· The CDRs of Rl9.9 contain a striking number of aromatic side chains, mostly tyrosines, which are oriented in such a way that they expose their phenolic OH groups to the solvent (see Fig. 4 ). These include the VH tyrosines 27, 32, 57, 101, and 109. VH Phe-100 in this region is also exposed to the solvent. V H Phe-29, Tyr-50, and Tyr-110 are oriented towards the interior of the structure, thus precluding their participation in contacts with ligands. In VL, Tyr-32, Tyr-49, and Tyr-50 are oriented with their side chains pointing towards the solvent. Thus, a total of nine aromatic side chains belonging to the V H and V L CD Rs, mostly tyrosines, are positioned to provide possible contacts with antigen. The prevalence of tyrosine residues in these CDRs has been noted Proc. Natl. Acad. Sci. USA 86 (1989) by Jeske et al. (46) , although orientations of these residues were not known.
Site-directed mutagenesis (47) and chain recombination studies (48) have implicated V H Ser-99 and V L Arg-96, respectively, as residues that are important in Ar binding. Inspection of the model of Fab R19.9 shows that the guanidino group of V L Arg-96 is at the bottom of the narrow cavity between V H and V L and that it could participate in direct contacts with an Ar ligand. Thus, it provides a positively charged group that could neutralize the negative charge of the Ar hapten. Ser-99 in VH appears less accessible to interactions with an external ligand. However, it and Arg-96 may be important in hapten binding not only because they could contribute direct contacts with Ar but also through stabilizing interactions with other amino acid residues at the combining site of the antibody itself. A precise identification of residues contacting bound Ar will require the determination of the three-dimensional structure of a hapten-Fab complex.
The presence of a long VH CDR3 loop in R19.9 has two major effects on the structure of the combining site: (i) it partially fills what otherwise would be a large cavity or depression surrounded by the other CD Rs of V Hand V L; and (ii) it provides a protruding structural feature that appears unique to R19.9 among other Fab structures that have been determined. It is interesting to compare this loop with that of human VH KOL (38) . Although KOL's CDR3 is three amino acids longer, it is partially bent inwards, thus resulting in a less salient loop than that of R19.9 (Fig. 4) .
The anti-Ar mAb R19.9 expresses some but not all idiotopes associated with CRIA. The nucleotide and amino acid sequences of its V H and V" regions are consistent with the possibility that they are somatic variants of the germ-line V H and V" genes that encode CRIA antibodies ( Figs. 1 and 2 ). In addition, Rl9.9 utilizes the canonical JH2 of CRIA. A major distinction in R19.9 is the contribution of a D gene segment giving rise to an atypical CDR3 that contains three more amino acid residues than are present in mAbs that fully express CRIA. The typical eight-residue D sequence appears to arise from the DFL16.1 genetic segment (10) . The unusual, longer D segment as well as the three amino acid substitutions in V ff CDR2 are likely to account for the incomplete expression of CRIA idiotopes in R19.9. In agreement with this conclusion, the L chain ofR19.9, when combined with the H chain of a CRIA mAb, yields a recombinant molecule that expresses CRIM whereas the converse recombinant, HR19.9LcR1 is idiotypically inactive (14) .
The partial idiotypic cross-reactivity between R19.9 and CRI.t mAbs can be explained by the presence, in antiidiotype sera, of antibodies that recognize residues in V H and VL other than those in VH CDR3 . Small differences in the primary structure of Rl9.9 and the germ-line-encoded structure owing to somatic mutations, as well as the large difference in D-region structure, could also contribute to the lack of total identity in serological tests. Among the somatic variations, the change from Ile-34 to Val in VH R19.9 does not seem adequate to explain a change in antigenic properties since the amino acid side chain at that position is not exposed. The sequence variations observed at positions Lys-55, Tyr-57, Leu-58, and Ser-59 in CDR2 and Arg-74 in FR3 could readily affect recognition of idiotopes since they are exposed at the accessible surface of Vff.
Characterization of two antigenic determinants occurring on a native protein (41, 44) indicates that the antigenantibody interface extends over an area of about 700 A 2 and includes residues from each of the V ff and V L CD Rs. Contacts with an anti-idiotype antibody might similarly include residues from all CDRs. Thus, given the solventexposed location and the spatial proximity of the CDR loops it is most reasonable to expect that the V Las well as V H CD Rs will contribute to many combining-site related idiotopes.
Note Added in Proof. After this paper was submitted for publication, Stevens et al. (49) reported differences in low and high ionic strength crystalline forms of human immunoglobulin L-chain dimer Loe, which they take to indicate different potential conformations of an antibody. The different VL-VL contacts observed in Loe, as well as those between VH and VL domains in FabNC41 complexed to antigen (45) , are postulated (49) to increase antigenic and idiotypic specificities ofantibodies. However, as shown in Table 2 , the V H-V L contacts observed in NC41 are within the range observed in Fabs, independently of their liganded (Dl.3 and Hy5) or nonliganded states. Since Table 2 includes Fabs crystallized at low (Hy5, Dl.3, and R19.9) and high ionic strength (Kol, New, J539, and McPC603), the conformational variations observed in Loe may be unique to it or to L chains, which do not normally occur as dimers in nature. The lack of significant differences in the relative disposition of V Hand V L thus far observed in liganded or unliganded Fahs does not seem to suggest that such differences could contribute to increase the functional diversity of antibodies.
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